Argan (AGX) EBITDA (2010 - 2026)

Argan has reported EBITDA for 17 years, with the latest figure at $47.7 million in Q1 2026.

• Quarterly EBITDA rose 45.93% year-over-year to $47.7 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $134.7 million (up 52.73% YoY) and the FY2026 annual result came in at $134.7 million, up 52.73% from the prior year.
• EBITDA climbed to $47.7 million in Q1 2026 per AGX's latest filing, from $32.6 million in the prior quarter.
• Over five years, EBITDA peaked at $47.7 million in Q1 2026 and troughed at -$1.2 million in Q1 2022.
• A 5-year average of $17.6 million and a median of $13.2 million in 2023 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2023: EBITDA slumped 109.92% in 2022, then soared 911.71% in 2023.
• Over 5 years, EBITDA stood at $9.5 million in 2022, then fell by 17.62% to $7.9 million in 2023, then soared by 285.9% to $30.3 million in 2024, then climbed by 7.59% to $32.6 million in 2025, then jumped by 46.08% to $47.7 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $47.7 million, $32.6 million, and $30.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.